DETERMINING THE POTENCY OF CARDIAC REHABILITATION PHASE- II IN CVD PATIENTS WITH CO-MORBIDITIES

Abstract

Globally, cardiovascular disease is a leading cause of mortality and
it is estimated that CVD is a cause of approximately 29.6% of all the
deaths worldwide. According to a research published in 2015 in
American journal of Cardiology it is a time to “rebrand and reinvigorate”
the cardiac rehabilitation program as the existing program
appears to be neither financially practicable nor maintainable
mainly due to affordability barriers. A Quasi experimental study was
conducted on 40 participants whom were diagnosed with cardiovascular
disease with comorbidities (diabetes mellitus and dyslipidemia).
Participants were asked to enroll in phase-II cardiac rehabilitation
program on the recommendation of the cardiologist and
were given intervention based on the guideline of American
College of Sports medicine. Six weeks of supervised exercise protocol
was conducted and its dosage was measured via Frequency,
Intensity, Time and Type (FITT) protocol. While for determining the
potency of phase-II Cardiac Rehabilitation program assessment of
the outcome measures were made after every sessions and the
results obtained from the assessment had revealed that for a CVD
patients with diabetes 24 hours of exercise which would be
performed for not less than four weeks provides a maximal result
which carried on for further two weeks whereas for CVD patients
with Dyslipidemia 20 hours of exercise had provided a desired result
carried on for the remaining weeks. The study concluded that
exercises based cardiac rehabilitation had a significant impact in
improving the patient condition where a six week of training protocol
improves the outcome measures included in the study.